Publikationen
Eine lange Liste von internationalen Publikationen zeugt von jahrzehntelanger Forschungstätigkeit auf mehreren Gebieten der Neurologie. Detaillierte Informationen hierüber entnehmen Sie bitte meinem Curriculum vitae und den wissenschaftlichen Arbeiten, die hier gelistet sind. Danke.
Diese wissenschaftliche Tätigkeit prägte seit jeher auch mein klinisches Verständnis und bestimmte auch meine zunehmende Spezialisierung bzw. Schwerpunkte in verschiedenen Bereichen der Neurologie.
Bei der klinisch-wissenschaftlichen Forschung und Publikation hatte die Unabhängigkeit von der Industrie für mich von Anfang an und bis zum heutigen Tag oberste Priorität.
2016 veröffentlichte ich das Buch die „Pharma Falle“ im Verlag edition a. Ich wollte aufzeigen und aufklären, nicht anklagen. So versuchte ich, Bewusstsein zu schaffen und auch Verbesserungsvorschläge zu machen, die zumindest teilweise Beachtung fanden.
Internationale Publikationen
2021
Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis.
Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P.
Ther Adv Chronic Dis. 2021; 28; 12: 20406223211024366.
2019
Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
Hegen H, Walde J, Milosavljevic D, Aboulenein-Djamshidian F, Senel M, Tumani H, Deisenhammer F, Presslauer S.
Clin Chem Lab Med. 2019; 57: 1574-1586.
Month-of-birth-effect in multiple sclerosis in Austria.
Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.
Mult Scler. 2019; 25: 1870-1877. Epub 2018 Nov 22.
2018
Secondary dementia due to Lyme neuroborreliosis.
Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P, Kristoferitsch W.
Wien Klin Wochenschr. 2018; 15-16: 468-478
2016
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M.
J Neuroinflammation 2016 Jul 1; 13: 176
2015
CROP – The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W
PLoS One 2015; 10: e0142272
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
Schanda K, Waters P, Holzer H, Aboulenein-Djamshidian F, Leite MI, Palace J, Vukusic S, Marignier R, Berger T, Reindl M
Neurol Neuroimmunol Neuroinflamm 2015; 2: e160
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M
Neurol Neuroimmunol Neuroinflamm 2015; 2: e141
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, Senel M, Tumani H, Hegen H
Mult Scler. 2015; 22: 502-510
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W
J Neuropathol Exp Neurol 2015; 74: 194-197
A case of variably protease-sensitive prionopathy treated with doxycyclin.
Assar H, Topakian R, Weis S, Rahimi J, Trenkler J, Höftberger R, Aboulenein-Djamshidian F, Ströbel T, Budka H, Yull H, Head MW, Ironside JW, Kovacs GG
J Neurology Neurosurg Psychiatry 2015; 86: 816-8
2014
Detection of retinal nerve fiber layer defects in Alzheimer‘s disease using SD-OCT.
Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher SC
Frontiers in Psychiatry 2014; 5:22
High-resolution spectral domain-optical coherence tomography in multiple sclerosis, Part II – the total macular volume. The first follow-up study over 2 years.
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Khan A, Vass C, Kristoferitsch W, Reitner A, Schmidt-Erfurth U
(*) equal contribution
Frontiers in Neurology 2014; 5:20
2013
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.
Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.
PLoS One 2013; 8: e79649
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays.
Höftberger R, Sabater L, Marignier R, Aboul-Enein F, Bernard-Valnet R, Rauschka H, Ruiz A, Blanco Y, Graus F,
Dalmau J, Saiz A.
PLoS One 2013; 8: e79083
Natalizumab therapy for highly active pediatric multiple sclerosis.
Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van’s Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A.
JAMA Neurol 2013 70: 469-475
2011
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M.
J Neuroinflammation 2011 28; 8:184
High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years.
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.
PLoS One 2011; 6: e19843
equal contribution(*)
Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography.
Serbecic N, Beutelspacher SC, Aboul-Enein F, Kircher K, Reitner A, Schmidt-Erfurth U
Br J Ophthalmol 2011; 95: 804-810
2010
Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients.
Schmid S, Aboul-Enein F*, Pfisterer W, Birkner T, Stadek C, Knosp E.
equal contribution(*)
Neurosurgery, 2010; 67: 1703-1708
Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations.
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U
(*) equal contribution
PLoS One. 2010; 8: 5(11): e13877
Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and betaendorphin.
Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H
Endocrinology 2010; 151: 4801-4810
Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis.
Höftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, Berki T, Ovadi J, Lassmann H, Budka H, Kovacs GG
Glia 2010; 58: 1847-1857
Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W
PLoS One 2010; 20: 5(7):e11625
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M
PLoS One. 2010; 5:e10455
Diffuse white matter damage is absent in neuromyelitis optica.
Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W
AJNR 2010; 31: 76-79
2009
Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.
Serbecic N, Lahdou I, Scheuerle A, Höftberger R, Aboul-Enein F
Mol Vis 2009; 15:1312-24
Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study.
Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, Kristoferitsch W
Eur Radiol. 2009; 19: 2535-2543
Normal pressure hydrocephalus or neuroborreliosis?
Aboul-Enein F, Kristoferitsch W
Wien Med Wochenschr 2009; 159: 58-61
2008
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W
Brain 2008; 131: 3072-3080
Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.
Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC
J Neurooncol 2008; 87: 43-50
Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome.
Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, Kristoferitsch W
Neuropathol Appl Neurobiol 2008; 34: 248-252
2007
Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy.
Höftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtländer T, Oezen I, Amann G, Bernheimer H, Budka H, Berger J
Neurobiol Dis 2007; 28: 165-174
Acute cerebral white matter damage in lethal salicylate intoxication.
Rauschka H, Aboul-Enein F*, Bauer J, Nobis H, Lassmann H, Schmidbauer M
equal contribution (*)
Neurotoxicology. 2007; 28: 33-37
Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus.
Pfisterer WK, Aboul-Enein F, Gebhart E, Graf M, Aichholzer M, Mühlbauer M
Acta Neurochir 2007; 149: 983-990
2006
Late-onset metachromatic leukodystrophy: Genotype strongly influences phenotype.
Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J
Neurology 2006; 67: 859-63
Advanced Intercross Line Mapping of Eae5 Reveals Ncf-1 and CLDN4 as Candidate Genes for Experimental Autoimmune Encephalomyelitis.
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T
J Immunol 2006; 176: 6055-64
Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis.
Aboul-Enein F, Weiser P, Höftberger R, Lassmann H, Bradl M
Acta Neuropathol 2006; 111: 539-47
2005
Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?
Aboul-Enein F, Lassmann H
Acta Neuropathol 2005;109: 49-55
2004
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation.
Aboul-Enein F, Bauer J, Klein M, Schubart A, Flügel A, Ritter T, Kawakami N, Siedler F, Linington C, Wekerle H, Lassmann H, Bradl M
J Neuropathol Exp Neurol 2004; 63: 1284-96
Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study.
Loers G, Aboul-Enein F*, Bartsch U, Lassmann H, Schachner M
equal contribution (*)
Mol Cell Neurosci 2004; 27: 175-89
Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.
Höftberger R, Aboul-Enein F*, Brück W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H
equal contribution (*)
Brain Pathol 2004; 14: 43-50
2003
CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, Pena-Rossi C
J Neuroimmunol 2003; 145: 1-11
Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats.
Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, Olsson T, Lorentzen JC
Eur J Immunol 2003; 33: 1907-16
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions.
Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Bruck W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M
Brain 2003; 126: 1347-57
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.
Aboul-Enein F*, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H
equal contribution (*)
J Neuropathol Exp Neurol 2003; 62: 25-33
Deutschsprachige Publikationen
Das Will Rogers Phänomen in der Multiplen Sklerose.
Aboul-Enein F
CliniCum neuropsy. 2012; 5: 38-42
Anmerkungen zum “publication bias”
Aboul-Enein F
Neurologisch. 2011; 3: 52-53
Hochauflösende SD-OCT bei MS – erste Verlaufsstudie über 2 Jahre.
Aboul-Enein F
Neurologisch. 2011; 3: 54-60
OCT revisited. Korreliert die Retinaschichtdicke mit dem Hirngewicht. Ein kurzer Einblick.
Aboul-Enein F
Neurologisch. 2011; 1: 32-35
Komplikationen neuer MS-Therapien: Infektionsprophylaxe und Infektionen.
Aboul-Enein F
Neurologisch. 2011; S3: 18-21
Monoklonale Antikörper in der Therapie der Multiplen Sklerose.
Aboul-Enein F
Journal für Neurologie, Neurochirurgie und Psychiatrie. 2010; 11: 24-29
Neuromyelitis Optica (NMO) – erste Studie zur epidemiologischen Erfassung der NMO in Österreich.
Aboul-Enein F
Neurologisch. 2010; 4: 78-81
Neuromyelitis optica: Klinisches Syndrom, Sonderform der Multiplen Sklerose oder Krankheitsentität?
Aboul-Enein F, Kristoferitsch K
Journal für Neurologie, Neurochirurgie und Psychiatrie. 2006; 7: 21-27
Comments, letters to the editor etc.
Discrepancy of data? (comment to J Neurol Neurosurg Psychiatry 2010; 81:409-411 doi:10.1136/jnnp.2008.168070)
Aboul-Enein F, Kristoferitsch W.
JNNP. recent e-Letters; published 23 June 2010.
Comment on the article entitled ‘Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis’ by Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, Malikova I, Soulier E, Viout P, Ranjeva JP, Pelletier J, Audoin B.
Aboul-Enein F.
(comment to J Neurol Neurosurg Psychiatry 2010; doi:10.1136/jnnp.2010.213744)
JNNP. recent e-Letters; published 12 January 2011.
Comment on ‚Global N-Acetylaspartate Declines Even in Benign Multiple Sclerosis‘
Aboul-Enein F.
AJNR Am J Neuroradiol. 2011 Apr 28.
Optical coherence tomography in multiple sclerosis.
Aboulenein-Djamshidian F, Serbecic N, Kristoferitsch W.
Lancet Neurol. 2016; 15: 537-8.
OCT is an alternative to MRI for monitoring MS – NO.
Aboulenein-Djamshidian F, Serbecic N.
Mult Scler. 2018 doi: 10.1177/1352458518754366.
Weiterführende Informationen auch auf:
researchgate.net oder auf loop